HIV-IN-6

CAS No. 301357-74-4

HIV-IN-6( —— )

Catalog No. M35590 CAS No. 301357-74-4

HIV-IN-6 is an HIV viral inhibitor that inhibits the replication of the HIV virus.HIV-IN-6 has anti-HIV viral activity and works by targeting Src family kinases (SFK) (e.g., Hck) that interact with the viral Nef protein.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 56 In Stock
10MG 92 In Stock
25MG 181 In Stock
50MG 293 In Stock
100MG 426 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HIV-IN-6
  • Note
    Research use only, not for human use.
  • Brief Description
    HIV-IN-6 is an HIV viral inhibitor that inhibits the replication of the HIV virus.HIV-IN-6 has anti-HIV viral activity and works by targeting Src family kinases (SFK) (e.g., Hck) that interact with the viral Nef protein.
  • Description
    HIV-IN-6 is a HIV-Ⅰ viral replication inhibitor by targeting Src family kinases (SFK) that interact with Nef protein of the virus, such as Hck.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    301357-74-4
  • Formula Weight
    392.43
  • Molecular Formula
    C20H16N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (254.82 mM; Ultrasonic )
  • SMILES
    Oc1cccc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccccc2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Emert-Sedlak, et al. Targeting an hiv-1 nef-host cell kinase complex.
molnova catalog
related products
  • N.41

    N.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).

  • BMS-955176

    BMS-955176 (GSK-3532795) is a second-generation HIV-1 maturation inhibitor that exhibits potent activity (EC50=3.9±3.4 nM) against a library (n=87) of gag/pr recombinant viruses.

  • HIV-1 inhibitor 5b

    HIV-1 inhibitor 5b is a novel anti-HIV-1 compound that inhibits HIV-1 JR-CSF with EC50 of 1 nM without significant cytotoxicity (CC50>20 uM).